Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « Keywords » - entrée « Diabetes Mellitus, Type 2 (complications) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Diabetes Mellitus, Type 2 (chemically induced) < Diabetes Mellitus, Type 2 (complications) < Diabetes Mellitus, Type 2 (diagnosis)  Facettes :

List of bibliographic references indexed by Diabetes Mellitus, Type 2 (complications)

Number of relevant bibliographic references: 37.
[0-20] [0 - 20][0 - 37][20-36][20-40]
Ident.Authors (with country if any)Title
000044 (2020) Mai Sugahara ; Shinji Tanaka ; Tetsuhiro Tanaka [Japon] ; Hisako Saito ; Yu Ishimoto ; Takeshi Wakashima ; Masatoshi Ueda ; Kenji Fukui ; Akira Shimizu [Japon] ; Reiko Inagi ; Toshimasa Yamauchi [Japon] ; Takashi Kadowaki [Japon] ; Masaomi NangakuProlyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice.
000255 (2019) Gian Paolo Fadini [Italie] ; Veronica Sciannameo [Italie] ; Ivano Franzetti [Italie] ; Daniele Bottigliengo [Italie] ; Paola D'Angelo [Italie] ; Carmela Vinci [Italie] ; Paola Berchialla [Italie] ; Salvatore Arena [Italie] ; Raffaella Buzzetti [Italie] ; Angelo Avogaro [Italie]Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study.
000484 (2019) Anbok Lee [Corée du Sud] ; Sunmi Jo [Corée du Sud] ; Changhu Lee [Corée du Sud] ; Hyun-Hee Shin [Corée du Sud] ; Tae Hyun Kim [Corée du Sud] ; Ki Jung Ahn [Corée du Sud] ; Sung-Kwang Park [Corée du Sud] ; Heunglae Cho [Corée du Sud] ; Hye-Kyoung Yoon [Corée du Sud] ; Woo Gyeong Kim [Corée du Sud] ; Jiyoung Park [Corée du Sud] ; Yunseon Choi [Corée du Sud]Diabetes as a prognostic factor in HER-2 positive breast cancer patients treated with targeted therapy.
000492 (2019) Daniel J. Kent ; Cheryl N. Mcmahill-Walraven [États-Unis] ; Catherine A. Panozzo [États-Unis] ; Pamala A. Pawloski [États-Unis] ; Kevin Haynes [États-Unis] ; James Marshall [États-Unis] ; Jeffrey Brown [États-Unis] ; Bernadette Eichelberger [États-Unis] ; Catherine M. Lockhart [États-Unis]Descriptive Analysis of Long- and Intermediate-Acting Insulin and Key Safety Outcomes in Adults with Type 2 Diabetes Mellitus.
000830 (2018) Domenico Accili [États-Unis]Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
000936 (2018) Milton Packer [États-Unis]Do sodium-glucose co-transporter-2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis.
000A09 (2018) Hiddo J L. Heerspink [Pays-Bas] ; Dennis L. Andress [États-Unis] ; George Bakris [États-Unis] ; John J. Brennan [États-Unis] ; Ricardo Correa-Rotter [Mexique] ; Fan Fan Hou [République populaire de Chine] ; Dalane W. Kitzman [États-Unis] ; Donald Kohan [États-Unis] ; Hirofumi Makino [Japon] ; John Mcmurray [Royaume-Uni] ; Vlado Perkovic [Australie] ; Sheldon Tobe [Canada] ; Melissa Wigderson [États-Unis] ; Tingting Yi [États-Unis] ; Hans-Henrik Parving [Danemark] ; Dick De Zeeuw [Pays-Bas]Baseline characteristics and enrichment results from the SONAR trial.
000E61 (2017) Aurélien Mary [France] ; Agnes Hartemann [France] ; Sophie Liabeuf [France] ; Carole Elodie Aubert [France, Suisse] ; Salim Kemel [France] ; Joe Elie Salem [France] ; Philippe Cluzel [France] ; Aurélie Lenglet [France] ; Ziad A. Massy [France] ; Jean-Daniel Lalau [France] ; Romuald Mentaverri [France] ; Olivier Bourron [France] ; Saïd Kamel [France]Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients.
000F38 (2016) Jay J. Salazar [États-Unis] ; William J. Ennis [États-Unis] ; Timothy J. Koh [États-Unis]Diabetes medications: Impact on inflammation and wound healing.
001088 (2016) Sudesna Chatterjee [Royaume-Uni] ; Kamlesh Khunti [Royaume-Uni] ; Melanie J. Davies [Royaume-Uni]Optimizing management of glycaemia.
001093 (2016) Alan R. Saltiel [États-Unis]New therapeutic approaches for the treatment of obesity.
001384 (2015) Francesc Formiga [Espagne] ; Ram N Re E [Espagne] ; Manuel Pérez-Maraver [Espagne][Dementia and diabetes: casual or causal relationship?].
001689 (2015) Kyoung Ja Kwon [Corée du Sud] ; Eun Joo Lee [Corée du Sud] ; Min Kyeong Kim [Corée du Sud] ; Soo Young Kim [Corée du Sud] ; Jung Nam Kim [Corée du Sud] ; Jin Ok Kim [Corée du Sud] ; Hee-Jin Kim [Corée du Sud] ; Hahn Young Kim [Corée du Sud] ; Jung-Soo Han [Corée du Sud] ; Chan Young Shin [Corée du Sud] ; Seol-Heui Han [Corée du Sud]Diabetes augments cognitive dysfunction in chronic cerebral hypoperfusion by increasing neuronal cell death: implication of cilostazol for diabetes mellitus-induced dementia.
001988 (2014) Sérgio H S. Santos [Brésil] ; Jorge F. Giani ; Valeria Burghi ; Johanna G. Miquet ; Fatimunnisa Qadri ; Janaina F. Braga ; Mihail Todiras ; Katarina Kotnik ; Natalia Alenina ; Fernando P. Dominici ; Robson A S. Santos ; Michael BaderOral administration of angiotensin-(1-7) ameliorates type 2 diabetes in rats.
001A37 (2014) Jen-Chieh Lin [Taïwan] ; Wen-Yi Shau [Taïwan] ; Mei-Shu Lai [Taïwan]Long-acting insulin analogues and diabetic retinopathy: a retrospective cohort study.
001B08 (2014) R. Boussageon [France] ; F. Gueyffier [France] ; C. Cornu [France]Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?
001E80 (2013) N. Irwin [Royaume-Uni] ; K. Hunter ; I A Montgomery ; P R FlattComparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
001F73 (2012) Linda Vona-Davis [États-Unis] ; David P. RoseType 2 diabetes and obesity metabolic interactions: common factors for breast cancer risk and novel approaches to prevention and therapy.
001F99 (2012) Spyridon Karras [Grèce] ; Dimitrios G. Goulis ; Gesthimani Mintziori ; Niki Katsiki ; Themistoklis TzotzasThe effects of incretins on energy homeostasis: physiology and implications for the treatment of type 2 diabetes mellitus and obesity.
002100 (2012) Thomas Quentin [Allemagne] ; Michael Steinmetz ; Andrea Poppe ; Sven ThomsMetformin differentially activates ER stress signaling pathways without inducing apoptosis.
002195 (2012) Adedayo A. Onitilo [États-Unis] ; Jessica M. Engel ; Ingrid Glurich ; Rachel V. Stankowski ; Gail M. Williams ; Suhail A. DoiDiabetes and cancer II: role of diabetes medications and influence of shared risk factors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Diabetes Mellitus, Type 2 (complications)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Diabetes Mellitus, Type 2 (complications)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Diabetes Mellitus, Type 2 (complications)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020